OrbiMed Private Investments VIII, LP Plans to Sell Shares in Disc Medicine, Inc.

OrbiMed Private Investments VIII, LP has filed a Form 144 with the SEC indicating its intention to sell 746,171 shares of common stock in Disc Medicine, Inc. The shares were acquired on December 29, 2022, through a business combination. The planned sale is expected to occur around October 20, 2025, with an aggregate market value of approximately $67,110,619.74. OrbiMed Capital GP VIII LLC is the general partner of OrbiMed Private Investments VIII, LP, and OrbiMed Advisors LLC is the managing member of OrbiMed Capital GP VIII LLC. The filing also confirms that there have been no sales of securities in the past three months.